Ironwood repays $200M 1.50% convertible notes due 2026 at maturity

IRONWOOD PHARMACEUTICALS INC

Repaid $200M aggregate principal of 1.50% convertible senior notes due 2026 at scheduled maturity.
Funded repayment with available cash on hand; no conversions exercised by holders.
Capped call transactions previously entered into in connection with notes terminated upon expiry.

item 8.01

IRONWOOD PHARMACEUTICALS INC filing history →

Source: SEC EDGAR

accession 0001104659-26-074023

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.